Latest filing published 12 Jun 2024 for DermTech, Inc., €141.
Kevin M. Sun (finance chief) discloses dealings in DermTech, Inc. to SEC (Form 4). The record holds 22 filings, for trades running from 17 January 2020 to 10 June 2024.
Every open-market trade on record is a sale: 14 sales worth €459k. Outside the open market, there are 8 share grants.
The latest filing, published on 12 June 2024, reports a share grant of €141 in DermTech, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations